d:YAG picosecond laser treatment for melanocytic naevi

Phase 2

Recruiting

• Conditions: melanocytic naevi; naevi; D009508

• Registration Number: JPRN-jRCTs052230007
• Lead Sponsor: Yuki Yamamoto

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-04-11
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Male or female More than 1 month old. melanocytic naevi presented on the head, face, trunk, arm or leg.,who was diagnosed by skin biopsy.

Exclusion Criteria

Patient with having severe underlying disease, pre
gnancy or lactation, Photosensivity, Porphyria, cardiac conduction
disturbance, allergic conditioned, local anesthesia
allergies, vascular or bleeding disorders, treatedwith anticoagulant therapy, autoimmune disease, t
reated with immunosuppressive therapy, keloid sc
ar formation, hypertrophic scar formation, maligna
nt skin tumor, pigment anomaly, inflammatory dise
ase that a symptom may aggravate in irritation by
a treatment, medical history of herpesvirus infecti
on. Invasive aesthetic treatments or surgery on the navi
within 6 months prior to the study enrollment.
Physical or chemical aesthetic treatments on the naevi within 3
month prior to the study enrollment.

Study & Design

• Study Type: Interventional
• Study Design: Not specified